{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:36:02Z","timestamp":1791394562701,"version":"4.3.3"},"reference-count":129,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,10,5]],"date-time":"2015-10-05T00:00:00Z","timestamp":1444003200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jacc.2015.09.075","type":"journal-article","created":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T16:02:25Z","timestamp":1448294545000},"page":"2451-2466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":424,"title":["Diagnosis, Prognosis, and Therapy of\u00a0Transthyretin Amyloidosis"],"prefix":"10.1016","volume":"66","author":[{"given":"Morie A.","family":"Gertz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merrill D.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Dyck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Grogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terresa","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violaine","family":"Plante-Bordeneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut H.J.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaolo","family":"Merlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2015.09.075_bib1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/jsbi.2000.4221","article-title":"Review: history of the amyloid fibril","volume":"130","author":"Sipe","year":"2000","journal-title":"J\u00a0Struct Biol"},{"key":"10.1016\/j.jacc.2015.09.075_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1515\/bmc-2013-0038","article-title":"Transthyretin: a multifaceted protein","volume":"5","author":"Vieira","year":"2014","journal-title":"Biomol Concepts"},{"key":"10.1016\/j.jacc.2015.09.075_bib3","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.2174\/092986712800269335","article-title":"Nearly 200 X-ray crystal structures of transthyretin: what do they tell us about this protein and the design of drugs for TTR amyloidoses?","volume":"19","author":"Palaninathan","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jacc.2015.09.075_bib4","doi-asserted-by":"crossref","first-page":"7255","DOI":"10.1039\/C4CP04549A","article-title":"A\u00a0look into amyloid formation by transthyretin: aggregation pathway and a novel kinetic model","volume":"17","author":"Faria","year":"2015","journal-title":"Phys Chem Chem Phys"},{"key":"10.1016\/j.jacc.2015.09.075_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/BF00210422","article-title":"Haplotype analysis of common transthyretin mutations","volume":"96","author":"Almeida","year":"1995","journal-title":"Hum Genet"},{"key":"10.1016\/j.jacc.2015.09.075_bib6","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1136\/jmg.2003.014803","article-title":"Common origin of the Val30Met mutation responsible for the amyloidogenic transthyretin type of familial amyloidotic polyneuropathy","volume":"41","author":"Ohmori","year":"2004","journal-title":"J\u00a0Med Genet"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2015.09.075_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/13506129.2012.670813","article-title":"Regional differences and similarities of FAP in Sweden","volume":"19","author":"Hellman","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1172-8-31","article-title":"Guideline of transthyretin-related hereditary amyloidosis for clinicians","volume":"8","author":"Ando","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jacc.2015.09.075_bib9","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/01.CIR.83.3.808","article-title":"Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis: a Doppler echocardiography study","volume":"83","author":"Klein","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.09.075_bib10","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0002-9149(97)00400-1","article-title":"Right ventricular dilation in primary amyloidosis: an independent predictor of survival","volume":"80","author":"Patel","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2015.09.075_bib11","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.ejheart.2007.05.006","article-title":"Importance of the echocardiographic evaluation of right ventricular function in patients with AL amyloidosis","volume":"9","author":"Ghio","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2015.09.075_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/eurheartj\/ehi040","article-title":"Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques","volume":"26","author":"Modesto","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2015.09.075_bib13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/13506129.2012.685131","article-title":"Arterial thromboembolism in senile systemic amyloidosis: report of two cases","volume":"19","author":"Nakagawa","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib14","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.amjcard.2015.05.021","article-title":"Characterization of cardiac amyloidosis by atrial late gadolinium enhancement using contrast-enhanced cardiac magnetic resonance imaging and correlation with left atrial conduit and contractile function","volume":"116","author":"Kwong","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2015.09.075_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","article-title":"Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study","volume":"6","author":"Banypersad","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2015.09.075_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrcardio.2014.165","article-title":"Pathophysiology and treatment of cardiac amyloidosis","volume":"12","author":"Gertz","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2015.09.075_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10741-014-9462-7","article-title":"Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs","volume":"20","author":"Casta\u00f1o","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacc.2015.09.075_bib18","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.jacc.2009.12.040","article-title":"Infiltrative cardiovascular diseases: cardiomyopathies that look alike","volume":"55","author":"Seward","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.09.075_bib19","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","article-title":"Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types","volume":"120","author":"Rapezzi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.09.075_bib20","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.humpath.2011.03.004","article-title":"High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly","volume":"42","author":"Sekijima","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jacc.2015.09.075_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1185\/03007995.2012.754348","article-title":"THAOS: The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis","volume":"29","author":"Coelho","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jacc.2015.09.075_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/13506129.2015.1019610","article-title":"Hereditary ATTR amyloidosis: a single-institution experience with 266 patients","volume":"22","author":"Swiecicki","year":"2015","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa1404852","article-title":"The\u00a0amyloidogenic V122I transthyretin variant in elderly black Americans","volume":"372","author":"Quarta","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.09.075_bib24","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.jacc.2006.01.042","article-title":"Transthyretin V122I in African Americans with congestive heart failure","volume":"47","author":"Buxbaum","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.09.075_bib25","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ahj.2009.08.006","article-title":"Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis","volume":"158","author":"Connors","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2015.09.075_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/13506120410001673884","article-title":"End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors","volume":"11","author":"Lobato","year":"2004","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0002-9343(96)00229-X","article-title":"The premortem recognition of systemic senile amyloidosis with cardiac involvement","volume":"101","author":"Kyle","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2015.09.075_bib28","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/archinte.165.12.1425","article-title":"Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis","volume":"165","author":"Ng","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2015.09.075_bib29","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ahj.2012.04.015","article-title":"Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS)","volume":"164","author":"Ruberg","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2015.09.075_bib30","doi-asserted-by":"crossref","first-page":"e000098","DOI":"10.1161\/JAHA.113.000098","article-title":"Senile systemic amyloidosis: clinical features at presentation and outcome","volume":"2","author":"Pinney","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2015.09.075_bib31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/13506120600876849","article-title":"Myocardial hypertrophy and function are related to age at onset in familial amyloidotic polyneuropathy","volume":"13","author":"Suhr","year":"2006","journal-title":"Amyloid"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2015.09.075_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/13506129.2012.685665","article-title":"Regional difference and similarity of familial amyloidosis with polyneuropathy in France","volume":"19","author":"Adams","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/1054-8807(94)00023-K","article-title":"Amyloidosis and endomyocardial biopsy: Correlation of extent and pattern of deposition with amyloid immunophenotype in 100 cases","volume":"4","author":"Crotty","year":"1995","journal-title":"Cardiovasc Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2015.09.075_bib34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3109\/13506129.2012.674074","article-title":"Senile systemic amyloidosis: are regional differences real or do they reflect different diagnostic suspicion and use of techniques?","volume":"19","author":"Falk","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/13506120500107162","article-title":"A\u00a0prospective evaluation of the transthyretin Ile122 allele frequency in an African-American population","volume":"12","author":"Yamashita","year":"2005","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib36","first-page":"1074","article-title":"Incidence of amyloidosis over 3 years: the AMYPRO study","volume":"26","author":"Magy-Bertrand","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jacc.2015.09.075_bib37","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/07853890701842988","article-title":"Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in\u00a0alpha2-macroglobulin and tau: a population-based autopsy study","volume":"40","author":"Tanskanen","year":"2008","journal-title":"Ann Med"},{"key":"10.1016\/j.jacc.2015.09.075_bib38","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/PAS.0b013e3181788566","article-title":"Prevalence of germline mutations in the TTR gene in a consecutive series of surgical pathology specimens with ATTR amyloid","volume":"33","author":"Eriksson","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jacc.2015.09.075_bib39","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00428-010-0909-5","article-title":"Amyloid in endomyocardial biopsies","volume":"456","author":"Kieninger","year":"2010","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jacc.2015.09.075_bib40","doi-asserted-by":"crossref","first-page":"W394","DOI":"10.2214\/AJR.09.3721","article-title":"MRI of cardiac involvement in transthyretin familial amyloid polyneuropathy","volume":"195","author":"Di Bella","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacc.2015.09.075_bib41","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/eurheartj\/ehs123","article-title":"Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2015.09.075_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/13506129.2012.761967","article-title":"Evaluation of patients with cardiac amyloidosis using echocardiography, ECG and right heart catheterization","volume":"20","author":"Granstam","year":"2013","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/clc.22353","article-title":"Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis","volume":"38","author":"Cappelli","year":"2015","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2015.09.075_bib44","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/CIRCULATIONAHA.113.006242","article-title":"Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis","volume":"129","author":"Quarta","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.09.075_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/13506120902879681","article-title":"Tissue Doppler and strain imaging: a new tool for early detection of cardiac amyloidosis","volume":"16","author":"Porciani","year":"2009","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib46","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2015.09.075_bib47","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jacc.2007.10.049","article-title":"Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy","volume":"51","author":"Vogelsberg","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.09.075_bib48","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s11604-013-0238-0","article-title":"MRI differentiation of cardiomyopathy showing left ventricular hypertrophy and heart failure: differentiation between cardiac amyloidosis, hypertrophic cardiomyopathy, and hypertensive heart disease","volume":"31","author":"Takeda","year":"2013","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.jacc.2015.09.075_bib49","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3109\/13506129.2014.956924","article-title":"Noninvasive detection of cardiac involvement in patients with hereditary transthyretin associated amyloidosis using cardiac magnetic resonance imaging: a prospective study","volume":"21","author":"Deux","year":"2014","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","article-title":"CMR-based differentiation of AL and ATTR cardiac amyloidosis","volume":"7","author":"Dungu","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2015.09.075_bib51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2013.10.008","article-title":"Native T1 mapping in transthyretin amyloidosis","volume":"7","author":"Fontana","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2015.09.075_bib52","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/brain\/awu344","article-title":"In\u00a0vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography","volume":"138","author":"Kollmer","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.jacc.2015.09.075_bib53","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0002-9149(83)80140-4","article-title":"Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis","volume":"51","author":"Falk","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2015.09.075_bib54","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.09.075_bib55","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00259-010-1642-7","article-title":"Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy","volume":"38","author":"Rapezzi","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jacc.2015.09.075_bib56","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","article-title":"Role of 99mTc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis","volume":"4","author":"Rapezzi","year":"2011","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2015.09.075_bib57","doi-asserted-by":"crossref","first-page":"W256","DOI":"10.2214\/AJR.12.8737","article-title":"Comparison between 99mTc-diphosphonate imaging and MRI with late gadolinium enhancement in evaluating cardiac involvement in patients with transthyretin familial amyloid polyneuropathy","volume":"200","author":"Minutoli","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacc.2015.09.075_bib58","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/13506129.2011.638682","article-title":"Technetium pyrophosphate myocardial uptake and peripheral neuropathy in a rare variant of familial transthyretin (TTR) amyloidosis (Ser23Asn): a case report and literature review","volume":"19","author":"Castano","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"99mTc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2015.09.075_bib60","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12350-013-9800-5","article-title":"Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques","volume":"21","author":"Aljaroudi","year":"2014","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jacc.2015.09.075_bib61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/13506129.2013.871250","article-title":"Bone scintigraphy with 99mtechnetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis","volume":"21","author":"Glaudemans","year":"2014","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib62","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jcmg.2014.03.004","article-title":"Identification of TTR-related subclinical amyloidosis with 99mTc-DPD scintigraphy","volume":"7","author":"Longhi","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2015.09.075_bib63","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jcmg.2014.03.002","article-title":"Noninvasive risk stratification of patients with transthyretin amyloidosis","volume":"7","author":"Kristen","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2015.09.075_bib64","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2796.2007.01888.x","article-title":"Do troponin and B-natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis?","volume":"263","author":"Suhr","year":"2008","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jacc.2015.09.075_bib65","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/13506120903421538","article-title":"Serum levels of NT-proBNP as surrogate for cardiac amyloid burden: new evidence from gadolinium-enhanced cardiac magnetic resonance imaging in patients with amyloidosis","volume":"16","author":"Lehrke","year":"2009","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib66","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/13506129.2013.825240","article-title":"Role of natriuretic peptide to predict cardiac abnormalities in patients with hereditary transthyretin amyloidosis","volume":"20","author":"Damy","year":"2013","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib67","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/13506129.2013.844122","article-title":"Usefulness of plasma B-type natriuretic peptide as a prognostic marker of cardiac function in senile systemic amyloidosis and in familial amyloidotic polyneuropathy","volume":"20","author":"Usuku","year":"2013","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib68","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/13506129.2011.623199","article-title":"Diagnostic value of abdominal wall fat pad biopsy in senile systemic amyloidosis","volume":"18","author":"Ikeda","year":"2011","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib69","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.amjcard.2014.02.030","article-title":"Yield of noncardiac biopsy for the diagnosis of transthyretin cardiac amyloidosis","volume":"113","author":"Fine","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2015.09.075_bib70","doi-asserted-by":"crossref","first-page":"354648","DOI":"10.1155\/2014\/354648","article-title":"Minimally invasive minor salivary gland biopsy for the diagnosis of amyloidosis in a rheumatology clinic","volume":"2014","author":"Mercan","year":"2014","journal-title":"ISRN Rheumatol"},{"key":"10.1016\/j.jacc.2015.09.075_bib71","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/modpathol.2011.117","article-title":"Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study","volume":"24","author":"Ueda","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jacc.2015.09.075_bib72","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/PAS.0b013e3182263d74","article-title":"Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing","volume":"35","author":"Satoskar","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jacc.2015.09.075_bib73","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/jclinpath-2014-202722","article-title":"A\u00a0comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue","volume":"68","author":"Gilbertson","year":"2015","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.jacc.2015.09.075_bib74","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1182\/blood-2011-06-358507","article-title":"Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients","volume":"119","author":"Sch\u00f6nland","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2015.09.075_bib75","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1182\/blood-2014-11-609883","article-title":"A\u00a0practical approach to the diagnosis of systemic amyloidoses","volume":"125","author":"Fern\u00e1ndez de Larrea","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2015.09.075_bib76","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3324\/haematol.2013.102764","article-title":"Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics","volume":"99","author":"Vrana","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jacc.2015.09.075_bib77","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10741-014-9464-5","article-title":"Natural history and therapy of AL cardiac amyloidosis","volume":"20","author":"Grogan","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jacc.2015.09.075_bib78","doi-asserted-by":"crossref","first-page":"989","DOI":"10.7326\/0003-4819-55-6-989","article-title":"Cardiac amyloidosis. Two cases with digitalis sensitivity","volume":"55","author":"Cassidy","year":"1961","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2015.09.075_bib79","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.CIR.63.6.1285","article-title":"Digoxin sensitivity in amyloid cardiomyopathy","volume":"63","author":"Rubinow","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2015.09.075_bib80","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/13506129.2013.821406","article-title":"The prognostic significance of central hemodynamics in patients with cardiac amyloidosis","volume":"20","author":"Russo","year":"2013","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib81","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.hrthm.2007.10.016","article-title":"Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death","volume":"5","author":"Kristen","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2015.09.075_bib82","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/jce.12123","article-title":"Implantable cardioverter defibrillators in patients with cardiac amyloidosis","volume":"24","author":"Lin","year":"2013","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2015.09.075_bib83","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.hrthm.2013.10.026","article-title":"Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis","volume":"11","author":"Varr","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2015.09.075_bib84","doi-asserted-by":"crossref","first-page":"E63","DOI":"10.1002\/clc.20389","article-title":"Cardiac amyloidosis treated with an implantable cardioverter defibrillator and subcutaneous array lead system: report of a case and literature review","volume":"32","author":"Dhoble","year":"2009","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2015.09.075_bib85","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.hrthm.2012.02.033","article-title":"Prophylactic pacemaker implantation in familial amyloid polyneuropathy","volume":"9","author":"Algalarrondo","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2015.09.075_bib86","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.healun.2013.01.987","article-title":"Left ventricular device implantation for advanced cardiac amyloidosis","volume":"32","author":"Swiecicki","year":"2013","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2015.09.075_bib87","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.healun.2015.03.012","article-title":"Role of ventricular assist therapy for patients with heart failure and restrictive physiology: improving outcomes for a lethal disease","volume":"34","author":"Grupper","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jacc.2015.09.075_bib88","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2013.10.033","article-title":"Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: a proteomic approach","volume":"170","author":"Tasaki","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2015.09.075_bib89","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/mus.10452","article-title":"Contribution of wild-type transthyretin to hereditary peripheral nerve amyloid","volume":"28","author":"Yazaki","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jacc.2015.09.075_bib90","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/13506120701614032","article-title":"Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation","volume":"14","author":"Liepnieks","year":"2007","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib91","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/13506120903090726","article-title":"Quality of life in patients with familial amyloidotic polyneuropathy long-term after liver transplantation","volume":"16","author":"Drent","year":"2009","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib92","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.bbrc.2008.12.095","article-title":"Proportion between wild-type and mutant protein in truncated compared to full-length ATTR: an analysis on transplanted transthyretin T60A amyloidosis patients","volume":"379","author":"Ihse","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jacc.2015.09.075_bib93","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/j.1600-6143.2009.02643.x","article-title":"Spanish Register for Heart Transplantation. Outcomes of heart transplantation for cardiac amyloidosis: subanalysis of the Spanish registry for heart transplantation","volume":"9","author":"Roig","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jacc.2015.09.075_bib94","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1212\/WNL.0b013e3181ea15d4","article-title":"Progression of transthyretin amyloid neuropathy after liver transplantation","volume":"75","author":"Liepnieks","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2015.09.075_bib95","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3109\/13506129.2011.615872","article-title":"Development of cardiomyopathy after liver transplantation in Swedish hereditary transthyretin amyloidosis (ATTR) patients","volume":"18","author":"Okamoto","year":"2011","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib96","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.23521","article-title":"Liver transplantation and transthyretin amyloidosis","volume":"47","author":"Benson","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jacc.2015.09.075_bib97","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/jnnp-2013-305973","article-title":"Changes in\u00a0pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation","volume":"85","author":"Oshima","year":"2014","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jacc.2015.09.075_bib98","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/jnnp-2014-308107","article-title":"CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings","volume":"86","author":"Maia","year":"2015","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jacc.2015.09.075_bib99","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/lt.24058","article-title":"Liver transplantation in transthyretin amyloidosis: issues and challenges","volume":"21","author":"Carvalho","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jacc.2015.09.075_bib100","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/TP.0000000000000574","article-title":"Liver Transplantation for hereditary transthyretin amyloidosis: after 20 years still the best therapeutic alternative?","volume":"99","author":"Ericzon","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.jacc.2015.09.075_bib101","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejcts.2007.10.025","article-title":"Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis","volume":"33","author":"Sack","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jacc.2015.09.075_bib102","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/ctr.12053","article-title":"Long-term outcome in patients treated with combined heart and liver transplantation for familial amyloidotic cardiomyopathy","volume":"27","author":"Nelson","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jacc.2015.09.075_bib103","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3109\/13506129.2013.853660","article-title":"Isolated heart transplantation for familial transthyretin (TTR) V122I cardiac amyloidosis","volume":"21","author":"Thenappan","year":"2014","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib104","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1600-6143.2008.02162.x","article-title":"Heart transplantation for homozygous familial transthyretin (TTR) V122I cardiac amyloidosis","volume":"8","author":"Hamour","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jacc.2015.09.075_bib105","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/ajt.13025","article-title":"Outcomes after heart transplantation for amyloid cardiomyopathy in the modern era","volume":"15","author":"Davis","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jacc.2015.09.075_bib106","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1517\/13543784.2014.922541","article-title":"An overview of drugs currently under investigation for the treatment of\u00a0transthyretin-related hereditary amyloidosis","volume":"23","author":"Obici","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jacc.2015.09.075_bib107","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jns.2014.06.041","article-title":"Retrospective study of a TTR FAP cohort to modify NIS+7 for therapeutic trials","volume":"344","author":"Suanprasert","year":"2014","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.jacc.2015.09.075_bib108","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00392-012-0463-z","article-title":"Green tea\u00a0halts progression of cardiac transthyretin amyloidosis: an observational report","volume":"101","author":"Kristen","year":"2012","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacc.2015.09.075_bib109","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/13506120600960882","article-title":"Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis","volume":"13","author":"Sekijima","year":"2006","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib110","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.neures.2006.08.014","article-title":"Diflunisal\u00a0stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis","volume":"56","author":"Tojo","year":"2006","journal-title":"Neurosci Res"},{"key":"10.1016\/j.jacc.2015.09.075_bib111","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1751-7133.2012.00303.x","article-title":"Diflunisal for ATTR cardiac amyloidosis","volume":"18","author":"Casta\u00f1o","year":"2012","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.jacc.2015.09.075_bib112","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1001\/jama.2013.283815","article-title":"Diflunisal Trial Consortium. Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial","volume":"310","author":"Berk","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.09.075_bib113","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jns.2014.07.017","article-title":"Efficacy of diflunisal on autonomic dysfunction of late-onset familial amyloid polyneuropathy (TTR Val30Met) in a Japanese endemic area","volume":"345","author":"Takahashi","year":"2014","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.jacc.2015.09.075_bib114","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jmb.2011.12.060","article-title":"The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug","volume":"421","author":"Johnson","year":"2012","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.jacc.2015.09.075_bib115","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","article-title":"Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial","volume":"79","author":"Coelho","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jacc.2015.09.075_bib116","first-page":"2802","article-title":"Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy","volume":"260","author":"Coelho","year":"2013","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.jacc.2015.09.075_bib117","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s12265-013-9512-x","article-title":"Effects of tafamidis on transthyretin stabilization and clinical outcomes in patients with non-Val30Met transthyretin amyloidosis","volume":"6","author":"Merlini","year":"2013","journal-title":"J\u00a0Cardiovasc Transl Res"},{"key":"10.1016\/j.jacc.2015.09.075_bib118","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/ene.12225","article-title":"Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy","volume":"20","author":"Lozeron","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jacc.2015.09.075_bib119","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s40265-014-0260-2","article-title":"Tafamidis: a review of its use in familial amyloid polyneuropathy","volume":"74","author":"Scott","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.jacc.2015.09.075_bib120","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/CIRCHEARTFAILURE.113.000890","article-title":"Tafamidis in transthyretin amyloid cardiomyopathy: effects on transthyretin stabilization and\u00a0clinical outcomes","volume":"8","author":"Maurer","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacc.2015.09.075_bib121","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.bbrc.2005.09.142","article-title":"Selective silencing of a mutant transthyretin allele by small interfering RNAs","volume":"337","author":"Kurosawa","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jacc.2015.09.075_bib122","doi-asserted-by":"crossref","first-page":"240ps7","DOI":"10.1126\/scitranslmed.3008362","article-title":"RNAi therapies: drugging the undruggable","volume":"6","author":"Wu","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jacc.2015.09.075_bib123","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1208760","article-title":"Safety and\u00a0efficacy of RNAi therapy for transthyretin amyloidosis","volume":"369","author":"Coelho","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.09.075_bib124","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/mus.20503","article-title":"Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides","volume":"33","author":"Benson","year":"2006","journal-title":"Muscle Nerve"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2015.09.075_bib125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/13506129.2012.673140","article-title":"Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy","volume":"19","author":"Ackermann","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib126","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1096\/fj.02-0764com","article-title":"4'-iodo-4'-deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in\u00a0vitro producing noncytotoxic species: screening for TTR fibril disrupters","volume":"17","author":"Cardoso","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.jacc.2015.09.075_bib127","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1479-5876-8-74","article-title":"Synergy of combined doxycycline\/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse models","volume":"8","author":"Cardoso","year":"2010","journal-title":"J\u00a0Transl Med"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2015.09.075_bib128","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/13506129.2012.678508","article-title":"Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study","volume":"19","author":"Obici","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.jacc.2015.09.075_bib129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature09494","article-title":"Antibodies to human serum amyloid P component eliminate visceral amyloid deposits","volume":"468","author":"Bodin","year":"2010","journal-title":"Nature"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109715067881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109715067881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:12:03Z","timestamp":1760015523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109715067881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":129,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0735109715067881"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2015.09.075","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis, Prognosis, and Therapy of\u00a0Transthyretin Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2015.09.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}